<DOC>
	<DOCNO>NCT02738125</DOCNO>
	<brief_summary>This study assess long‐term effectiveness adalimumab subject start treatment ulcerative colitis real life condition , namely describe time loss clinical benefit time event approach .</brief_summary>
	<brief_title>Assessing Effectiveness Adalimumab Treating Ulcerative Colitis Real Life Conditions</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Suffering ulcerative colitis Naïve Adalimumab Starting treatment adalimumab Capable willing grant authorization use/disclosure data collect Able read , understand , complete patient questionnaire</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>SOTHIS</keyword>
	<keyword>Adalimumab</keyword>
	<keyword>Ulcerative Colitis</keyword>
	<keyword>Effectiveness</keyword>
</DOC>